Pharmaceutical Giants Are Chasing R&D Deals With Smaller AI Startups
The first month of 2019 is not over yet, but there are already four major announcements about new research projects …
All Posts
Presenting a New Paradigm for Drug Discovery: Combining Computational Biophysics and AI through MatchMaker
In this Special Perspective, our fourth in an ongoing series, we will be presenting MatchMaker™, a novel deep proteome screening …
2018: AI Is Surging In Drug Discovery Market
Updated: 10.01.2019. Newly added content is marked in the text with "Update" sign. The idea of using artificial intelligence (AI) …
Will 2019 Bring Positive Signals for the Declining Antibiotics R&D Market?
Antibiotic R&D has had a particularly bad year starting with The Medicines Company who abandoned their antibiotic R&D efforts and …
Democratizing Artificial Intelligence For Pharmaceutical Research
Over the last five years the interest of pharmaceutical professionals towards machine learning (ML) and artificial intelligence (AI) has measurably …
A Reliable Molecular Structure Predictor in the Cloud
Since August Kekulé’s proposal for the tetrahedral configuration of carbon or his more famous realization that benzene was a cyclic …
Get Ready For “Super-platforms” In Healthcare and Pharmaceutical Research
What is a super-platform? A “super-platform” is a term which describes a relatively new phenomenon in a modern technological world …
Pharma and Healthcare AI Vendors Join Forces To Accelerate Progress In Drug Discovery
Today Basel is crowded with some of the top business and research leaders representing a young and rapidly growing industry …
Navigating In REAL Chemical Space To Find Novel Medicines (Now 3.8 Billion Molecules)
[Latest update: 27.07.2018] February 6 2018 will be marked in history as the day when an automobile embarked on a million …
The Future Of Drug Development in China
China has been becoming a research powerhouse in many fields of science, but it still is a minor player when …
How Latest Drug Candidates Were Discovered? (Retrospective Review, 2016-2017)
Recently D.G.Brown and J.Boström of AstraZeneca published an insightful analysis, where they reviewed lead generation research strategies behind 66 small …
The “Why”, “How” and “When” of AI in Pharmaceutical Innovation
(Edited version of this post originally appeared in Forbes) “It is not the strongest of the species that survives, nor …